Cross-doc KG disagreements · 3 unresolved
KG Disagreements Queue
Study
Severity
Study
Category
Field
Primary
Secondary
Actions
- criticalHLX-VEL-301dosing_rulealt_grade2_actionHold study drug until recovery to Grade ≤1Reduce dose one level and continue
- highHLX-VEL-301visit_windowc2d1_window_days±3 days±2 days
- medMB-1140-204lab_requirementtroponin_timingTroponin drawn pre-dose at every visitTroponin drawn only at screening and W…